chrisvoncsefalvay/vaers-outcomes huggingface dataset:
her mouth drooped; her eyes drooped; she started to stutter while talking; headache; This is a spontaneous report received from a Pfizer-sponsored Program.  A contactable consumer (patient) reported that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Dose 1) via an unspecified route of administration on 06Mar2021 (batch/lot number was not reported) as SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient asked if she receives the 2nd dose of the vaccine will she experience the same adverse events after she received her first dose. She experienced headache, her mouth drooped, her eyes drooped, and she started to stutter while talking after receiving the first dose. Event onset dates were not reported. The outcome of the events was unknown. The patient's second dose is on 09Apr2021.  Information on the batch/lot number has been requested.
This case was reported by a consumer via call center representative and described the occurrence of chills in a 70-year-old female patient who received SHINGRIX. On 10th May 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 10th May 2018, 10 hrs after receiving SHINGRIX, the patient experienced chills and fever. On 11th May 2018, the patient experienced erythema, strength loss of, headache and tiredness. On 11th May 2018, the outcome of the chills and fever were recovered/resolved. On 12th May 2018, the outcome of the erythema, strength loss of, headache and tiredness were recovered/resolved. The reporter considered the chills, erythema, strength loss of, fever and headache to be related to SHINGRIX. It was unknown if the reporter considered the tiredness to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. At 10:00 hours, the patient received SHINGRIX. The patient stated on Thursday night about 10 hours after receiving the vaccine she had chills and a high fever but didn't take her temperature. She was up all night but by morning the chills and fever had resolved. One day after vaccination, the patient experienced erythema, strength loss of, headaches and tiredness. She however was extremely tired and stayed in bed all day. She also had a headache and her body was red all over. All events were resolved by Saturday. This case has been linked with case US2018086794, reported by the same reporter.
CLIENT GIVEN PED/ADOLESCENT DOSE OF HEPATITIS A VACCINE INSTAED OF ADULT DOSE. DOSES WERE IN PAPER GOLD ENVELOPE  WITH "ADOLESCENT"SHORTENED TO ADOL AND NURSE READ IT AS ADULT. WHILE CHARTING THE MIX UP WAS DISCOVERED. CALLED SUPERVISOR AND CLIENT AND EXPLAINED. CLIENT AGREED TO COME UP TO HEALTH DEPT THE NEXT DAY FOR ANOTHER DOSE (ADULT) AS IT WAS TOO LATE FOR THEM TO COME UP THAT DAY BY THE TIME THIS RN CONTACTED THEM. THEY REPORTED THEIR PHONE HAD BEEN SHUT OFF. THEY DID NOT SHOW UP OR ANSWER THE PHONE THE NEXT DAY BUT CAME TO FLU CLINIC ON 10-30-2020 AND THIS RN HAD PROPER ADULT DOSE OF HEPATITIS A VACCINE READY AND ADMINISTERED TO CLIENT. CLIENT TOL WELL.
fever and chills 72 hours after vaccine given; fever and chills 72 hours after vaccine given; age: 2 Years; vaccine location: Left leg; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  A 2-year-old male patient received BNT162b2 (BNT162B2), on 24Jun2022 as dose 1, single (Batch/Lot number: unknown) at the age of 2 years, in left leg for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (non-serious) with onset 24Jun2022, outcome "unknown", described as "age: 2 Years"; PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (non-serious) with onset 24Jun2022, outcome "unknown", described as "vaccine location: Left leg"; CHILLS (non-serious), PYREXIA (non-serious) all with onset 27Jun2022, outcome "recovering" and all described as "fever and chills 72 hours after vaccine given". Therapeutic measures were not taken as a result of chills, pyrexia.  Clinical information: Vaccine facility type was other. No other vaccine in four weeks and no other medications in two weeks. The patient has no known allergies and no other medical history.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Fatigue (duration 2 days) Injection site pain (duration 2 days)  Headache (duration 12 hours)
I experienced fever of 100.9, chills, nausea, muscle cramps in left calf, and inability to raise left arm which was the injection site.
Initial low grade fever (101.2) with axillary discomfort.  Day 9-10, she had HA, diarrhea, fatigue.  Day 11-12 (3/2-3/3) she had a maculopapular vesicular pruritic rash on face and upper chest.
Nausea; Fever; Burning eyes; Body aches; Headache; Malaise; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 45-year-old male patient received BNT162b2 (COMIRNATY), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE: 3, First Booster, Manufacturer unknown), for Covid-19 Immunization; Covid-19 vaccine (DOSE: 2, Manufacturer unknown), for Covid-19 Immunization; Covid-19 vaccine (DOSE:1, Manufacturer unknown), for covid-19 immunization. The following information was reported: NAUSEA (non-serious), outcome "unknown"; PYREXIA (non-serious), outcome "unknown", described as "Fever"; EYE IRRITATION (non-serious), outcome "unknown", described as "Burning eyes"; PAIN (non-serious), outcome "unknown", described as "Body aches"; HEADACHE (non-serious), outcome "unknown"; MALAISE (non-serious), outcome "unknown".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
HEART WAS POUNDING OUT OF CHEST; COULD NOT BREATHE; THOUGHT WAS GOING TO DIE; FEVER; This spontaneous report received from a consumer concerned a 70 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced heart was pounding out of chest, could not breathe, thought was going to die, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the heart was pounding out of chest, could not breathe, fever and thought was going to die was not reported. This report was non-serious.
Full body hives going from face to legs. Itchiness and redness at site of bumps. Lasted off and on for at least 24 hours beginning at 8 PM
"Admitted to the hospital with complaints of generalized weakness; found to have COPD exacerbation and was treated with steroids, bronchodilators.    Patient was also noted to have COVID-19 infection.  He was treated with steroids and Actemra.   "
Initial and follow-up information has been received from a physician and a 25 year old female consumer with no medical history and no illness at time of vaccination who on 11-MAY-2009 was vaccinated with her first dose of GARDASIL into her left deltoid (Lot # 661953/1130X). The patient mentioned that she skipped her second dose (14-AUG-2009). The patient mentioned she was two months late. The patient stated that the first vaccination was very painful "like a nail". Follow-up information from the physician's office indicated that the patient had reported no adverse effects to the physician's office. No further information is available.
still contracted the corona virus; still contracted the corona virus; This is a spontaneous report from a contactable consumer or other non hcp(patient). A female patient of unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported and expiry date: unknown), dose 2 via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received dose 1 of bnt162b2 on an unknown date for COVID-19 immunization. The patient experienced still contracted the corona virus on an unspecified date. Outcome of the events were unknown.  Follow up(04Jun2021): This is a follow up spontaneous report from a consumer.  Information on the lot/batch number has been requested.
10/7-2 vaccines below received 10/8-ran high fever 103+ felt bad L arm warm and 50 cent knot reported, local inflammation with no cellulitis - She was seen urgent care and advised to take Benadryl - she also had tingling in L arm at site. Temp upper 90's rest of the week - 10/30 knot to arm still. Vomiting 10/8 x 5 - better on Thurs. 5 in family no one else sick.
chest tightness; sore throat pain 4 out of 5; right arm sore where injected; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat pain 4 out of 5), VACCINATION SITE PAIN (right arm sore where injected) and CHEST DISCOMFORT (chest tightness) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 19-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE PAIN (right arm sore where injected). On 21-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat pain 4 out of 5). On 22-Jan-2021, the patient experienced CHEST DISCOMFORT (chest tightness). At the time of the report, OROPHARYNGEAL PAIN (sore throat pain 4 out of 5), VACCINATION SITE PAIN (right arm sore where injected) and CHEST DISCOMFORT (chest tightness) outcome was unknown. Not Provided   No treatment information was provided.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Numbness and sensitivity on right side of face, nose, right nostril and upper lip; took Lyrica to see if this was a nerve issue; Numbness and sensitivity on right side of face, nose, right nostril and upper lip; took Lyrica to see if this was a nerve issue; This is a spontaneous report received from a contactable consumer (patient). A 77-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EL7Z69 ; expiry was not reported) via an unspecified route of administration on 10Feb2021 as single dose for covid-19 immunisation (at the age of 77 years). The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced numbness and sensitivity on right side of my face, nose, right nostril, and upper lip; and she took Lyrica (lot number: 19074111; Investigation Assessment: No) to see if this was a nerve issue and as therapeutic measures. She took a Lyrica this morning (12Feb2021) to see if this was a nerve issue and she took a Lyrica, Saturday as well. She was just checking to see if she had numbness and sensitivity on the right side of my face and the nose, the right nostril, and the upper lip of the mouth, was this a cause of the shot and is this the reason of Covid or not. The outcome of numbness and sensitivity on right side of face, nose, right nostril and upper lip; took Lyrica to see if this was a nerve issue was unknown.    Information about Lot/Batch number has been requested.
patint was given a expired dose of Tenivac/no AE; Initial information received on 03-Feb-2020 regarding an unsolicited valid non-serious case received from the other health professional.  This case involves a 25 year old female patient who was vaccinated with an 0.5 mL expired dose of DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] (lot number U5854AB and expiry date: 25-Jan-2020, frequency once) via an intramuscular route in the left deltoid on 29-Jan-2020.  Medical history, medical treatment, vaccination and family history were not provided. Concomitant medications included HPV VACCINE VLP RL1 4V (YEAST) (GARDASIL) for Immunisation.  It was a case of actual medication error due to expired vaccine used. It was reported that patient was given an expired dose of TENIVAC vaccine for prophylactic vaccination.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Within 15 minutes of receiving the vaccine, I felt pressure in my head. I felt a disorientation. The doctor present took my blood pressure and it was 152/85. My normal blood pressure was low/normal around 116/70. She asked if I wanted further medical assistance. I said no and she had me wait 15 minutes to half an hour. She took the blood pressure and it was down some. I made an appointment with my family physician and saw him within 2 days. My blood pressure was still up and he prescribed amlodipine 50 mg. I made an appointment with a cardiologist a couple of weeks later. My blood pressure was still up at this point. He prescribed a second medication, metoprolol. I've been on those medications since. My doctor had me get a brain scan that came back normal. The cardiologist had me do a MRI for my blood vessels that turned out normal as well. I've continued on both of these medications to this day. I've also experienced ongoing bouts of distress that I've treated with CBD. Those bouts of distress continue on a semi-regular basis. I've also experienced a COVID-19 infection back on 07/01/2022. There were minor flu like symptoms. Headache, body aches. I tested positive and went on PAXLOVID. I had a very minor case of COVID-19. I tested negative 6 days later.
Child's chronic skin rash returned, loss of appetite and weight loss. Child displayed lethargy. Had fever, vomiting, drowsiness, runny nose, irritability, excessive crying while awake, red painful swollen injection sight, vomiting, irritability, fatigue. Child displayed signs of post-traumatic stress, tried to hide behind parents, showed signs of desperation and distress when taken to the examine table, tried to isolate self from adults, panicked at the sight of nurse and doctor. Parents voiced concerned over the symptoms and explained to doctor this is why they did not think their daughter should continue vaccination schedule. Doctor told parents to find a different pediatrician and did not address the baby's obvious emotional and physical reactions to the vaccines.
pt recvd vax 28NOV94 @ noon;325PM pt devel fever of 105;fever persisted throughout noc;seen by MD 29NOV94;rx w/motrin;had several vomiting episodes 29NOV;fever persisted through 30NOV;also devel diarrhea;
10/15/2011 Awoke at 2am with pain in arm.  Woke up again at 8am, painful to lift arm. "Injection area red, approx. 3" around site then 3" band going down half way to elbow. 10/16/2011 states pain had subsided some.  On 10/17/2011 presented to HD.  Approx. 4" band going from injection site nearly to elbow.  Pink to light redness noted. Pt. was advised to see PMD.  10/18/2011 Spoke with patient.  States PMD placed him on Keflex, 500 mg. TID x 10 days.  States pain and redness have subsided some today.  Plans to follow up with his physician in December.
This patient came in on 12/08/2021 to get a Pneumococcal vaccine (PPSV23).  Due to language barrier patient identified as a different patient that was  to receive a Pfizer booster dose.  Patient had already received a Pfizer booster on 10/7/2021.   I informed the patient what side effects to watch for. I also advised the patient that I would reach out to her primary doctor tomorrow.
body aches 1 day, headache 1 day, fatigue 2 days, wheeze cough 2 days took tylenol
Information has been received from a nurse, for GARDASIL, a Pregnancy Registry product, concerning a pregnant female patient who on an unspecified date in 2009 ("in the last couple weeks") was accidentally vaccinated with a 0.5 ml dose of GARDASIL instead of flu vaccines. It was reported that the nurse had reached into her diebold dispenser to retrieve the flu vaccine syringes, but took out GARDASIL filled syringe instead. No adverse effect was reported. Unspecified medical attention was sought. It was unspecified which trimester the patient was in. This is one of several reports from the same source. No further information is available.
This spontaneous report as received from a other health professional refers to a male patient of unknown age and unknown ethnicity with routine vaccination. On 29-SEP-2014 the patient was vaccinated with ROTATEQ, (lot # was not provided), oral for routine vaccination. On 29-SEP-2014, 1 day after onset of therapy the patient experienced after an unspecified infant patient received a dose of ROTATEQ, he vomited and we are not sure he received the full dose and after an unspecified infant received  a dose of ROTATEQ, he vomited. When asked the patient's present status the nurse stated "he was back in the office today (date unknown) got another dose of ROTATEQ and was fine.  The outcome of after an unspecified infant patient received a dose of ROTATEQ, he vomited and we are not sure he received the full dose and after an unspecified infant patient received a dose ROTATEQ, he vomited is unknown. Action taken with the therapy drug was unknown. The reporter considered after unspecified infant patient received a dose of ROTATEQ, he vomited and we are not sure he received the full dose and after an unspecified infant patient received a dose of ROTATEQ, he vomited to be not related to ROTATEQ. Additional information is not expected.
Fever - 100 to 101 Chills Sweats Headache Sore arm
Headache started approximately one hour after administration of Moderna Vaccine Second Dose. The headache persists on the following day. Significant soreness at injection site. Flu-like symptoms of fatigue and muscle pain persist on day following administration
20 minutes after shot had a strange taste in my mouth. within a couple of minutes tongue began to tingle and about a minute or so later my lips started to tingle. The tingling in my tongue lasted for about 1 1/2 hours and the tingling in my lips lasted for about 2 hours. The strange tastye in my mouth went away in about 30 minutes.
Flu symptoms, including fever of 102.4, chills, headache, aches. (I know that the shot can give mild flu symptoms, but these were not mild!)
Mom called clinic on 3rd day p/immun had been given to report pt devel fever 105 & rash to neck & abdomen; Admitted to Hospital for tests & then released; COMMENT; Mom refused to sign for release of information;
Severe redness, tenderness at the sight of the injection; diagnosed with cellulitis and osteomyelitis in the upper right arm which coincides with the sight of the injections; symptoms appeared less than 36 hours after the immunization; admitted to the hospital through the emergency room for treatment of the above conditions; bone scan and MRI done to confirm diagnosis; IV antibiotics for six weeks through PICC line after discharge from hospital.  05/17/2007 MR received for a 3 night admit (4/27-30/07) for cellulitis and osteomyelitis of the Right shoulder where she had received Pneumovax. She developed fever, malaise, and generalized weakness the day following her vax. Fever increased the next day to 103.1'F and erythema and induration of the right shoulder developed with decreased ROM.   MRI revealed cellulitis and osteomyelitis of the right humerus so she was admitted for management. PE: WNL except severe erythema and induration of the R shoulder.  Tender to touch.  Decreased ROM.  Txd with IV abx and discharged with PICC line for home IV abx. Final DX:  Right Osteomyelitis and Cellulitis of the R proximal humerus.  SIRS 2' to Cellulitis.  Possibility of underlying immunodeficiency considering recurrent infections.
Patient stated injection site was swollen and warm to the touch for around 5 days, area cleared up without any treatment.
This spontaneous report as received from a registered nurse refers to 7 unspecified patients. On an unknown date in 2013 the patients were administered expired PNEUMOVAX23 (lot # 671038/0811AA, expiration 15-MAR-2013), injection, 0.5 ml, intramuscularly. No adverse effects reported. Additional information has been requested.
Swollen inner checks; Extreme arm pain; Fatigue; This is a spontaneous report from a contactable consumer (patient). A 48-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number and expiration date not reported), via an unspecified route of administration on 11Mar2021 13:00 (at the age of 48-years-old) at 1st dose, single dose in the left arm for COVID-19 immunization. The patient's medical history and concomitant medications were reported as none. The patient has no allergies to medications, foods, or other products. On 11Mar2021 23:00, the patient experienced swollen inner cheeks, extreme arm pain, and fatigue. The patient did not receive any treatment for the events. It was reported that the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, did not receive any other medications within 2 weeks of vaccination, has not been diagnosed with COVID-19 prior to vaccination, and has not been tested for COVID-19 since the vaccination. Outcome of all the events was reported as recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
On July 10th, after monitoring for several days, I had post nasal drip and a scratchy throat.  I did a home COVID-19 test and it was positive.  I contacted Dr., a friend of mine.  Sine he knows my history of asthma,  he suggested that I go to the hospital to get monoclonal antibodies.  After I left the hospital, walking back to the car, I felt very cold and have shivers.  After I drove home while feeling like I had a really bad flu.  I isolated from my family in bed.  I had no appetite.  I took Nyquil every six hours for my throat.  I had some chicken soup and within 15 minutes I had  uncontrollable diarrhea.  I began to have a very irritating, unproductive cough.  I have been sleeping a lot because I am so fatigued.  My oxygen level has been lower than normal for me.  As of today I have my appetite back a bit and feel a little better.  PO2 today is 93.  When I had the diarrhea, I was also nauseous at the time.  I also had a headache, kind of like a sinus headache.  Today I have a mild sinus headache.  My muscles cramped in my right leg and the left leg.  My calves were sore on day one.
About a week after receiving the first dose of the Moderna vaccine I began to feel ill. I don?t recall feeling any pain. My urine turned pink and I suspected I was bleeding, perhaps a UTI. When it continued for more than 2 days I went to a local urgent care clinic, saw a doctor there, submitted a urine sample for analysis and was sent home with a prescription for an antibiotic. However, the test result came back negative for bacteria and I discontinued the antibiotic. The bleeding eventually stopped. However, I did not feel well for several months, experiencing extreme fatigue well into the summer.